From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood
Metabolites · 24.04.2025 · 15 (5) · 287
DOI: 10.3390/metabo15050287 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 24.04.2025. Verfasst von Siham Accacha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 288 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is rapidly becoming the most prevalent form of chronic liver disease in both pediatric and adult populations. It encompasses a wide spectrum of liver abnormalities, ranging from simple fat accumulation to severe conditions such as inflammation, fibrosis, cirrhosis, and liver cancer. Major risk factors for MASLD include obesity, insulin resistance, type 2 diabetes, and hypertriglyceridemia.
Methods
This narrative review employed a comprehensive search of recent literature to identify the latest studies on the relationship between MAFLD and obesity, the health consequences and the latest treatment options to prevent long-term damage to the liver and other organs. Additionally, the article presents perspectives on diagnostic biomarkers.
Results
Childhood obesity is linked to a multitude of comorbid conditions and remains a primary risk factor for adult obesity. This abnormal fat accumulation is known to have long-term detrimental effects into adulthood. Scientific evidence unequivocally demonstrates the role of obesity-related conditions, such as insulin resistance, dyslipidemia, and hyperglycemia, in the development and progression of MASLD. Oxidative stress, stemming from mitochondrial dysfunction, is a leading factor in MASLD. This review discusses the interconnections between oxidative stress, obesity, dyslipidemia, and MASLD.
Conclusions
Atherogenic dyslipidemia, oxidative stress, inflammation, insulin resistance, endothelial dysfunction, and cytokines collectively contribute to the development of MASLD. Potential treatment targets for MASLD are focused on prevention and the use of drugs to address obesity and elevated blood lipid levels.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA.
- Department of Foundations of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA.
- Department of Medicine, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA.
ORCID-Profile: Ankita Srivastava, Allison B Reiss
Zitieren
APA
Accacha, S., Barillas-Cerritos, J., Srivastava, A., Ross, F., Drewes, W., Gulkarov, S., De Leon, J., & Reiss, A. B. (2025). From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood. Metabolites, 15(5), 287. https://doi.org/10.3390/metabo15050287
Vancouver
Accacha S, Barillas-Cerritos J, Srivastava A, Ross F, Drewes W, Gulkarov S, et al. From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood. Metabolites. 2025;15(5):287. doi:10.3390/metabo15050287
BibTeX
@article{Accacha2025,
author = {Accacha, Siham and Barillas-Cerritos, Julia and Srivastava, Ankita and Ross, Frances and Drewes, Wendy and Gulkarov, Shelly and De Leon, Joshua and Reiss, Allison B},
title = {From Childhood Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hyperlipidemia Through Oxidative Stress During Childhood},
journal = {Metabolites},
year = {2025},
volume = {15},
number = {5},
pages = {287},
doi = {10.3390/metabo15050287}
}
EUVIMED